The competition to develop advanced dexterous robotic hands, widely considered the most challenging hardware bottleneck in humanoid robotics, is intensifying in China, fueled by a massive influx of venture capital. On May 29, Hangzhou-based startup Xynova announced the completion of its Series A funding round, raising approximately 1 billion yuan (US$148 million). The round included participation from the venture arms of Xiaomi and Li Auto, two of China’s most prominent technology and automotive companies, and came just two months after Xynova’s previous funding injection, underscoring the frantic pace of investment in the sector.
AgiLink Achieves Unicorn Status in Record Time
Simultaneously, AgiLink, a company spun off from humanoid robot maker AgiBot in January 2026, has achieved unicorn status with a valuation surpassing US$1 billion. AgiLink completed four funding rounds in less than 150 days. According to the South China Morning Post, Wu Meimei, a senior analyst at ITJuzi, which tracks China’s venture capital market, described this rapid ascent as “unprecedented in the humanoid component sector.” The speed at which these companies are raising capital reflects the high stakes involved in mastering robotic manipulation, a critical capability for the widespread deployment of humanoid robots in industrial and domestic settings.
The focus on dexterous hands is driven by the complex engineering required to replicate human-like grasping and manipulation. Unlike the relatively straightforward mechanics of robotic legs or arms, hands require a dense integration of sensors, actuators, and sophisticated control algorithms to handle a wide variety of objects with varying shapes, weights, and fragilities. Xinhua has reported that this technical hurdle has made robotic hands a primary focus for investors looking to back the foundational technologies of the embodied AI revolution, which is expected to transform manufacturing, logistics, and service industries.
Strategic Backing from Tech and Auto Giants
The involvement of major tech and automotive players like Xiaomi and Li Auto in Xynova’s funding round highlights the strategic importance of this technology. These companies are increasingly viewing humanoid robotics as a natural extension of their existing capabilities in AI, manufacturing, and autonomous systems. Xiaomi, which committed 60 billion yuan to AI development, sees robotic dexterity as a key component of its long-term product roadmap. Li Auto, despite its recent financial challenges, is betting that expertise in AI-driven systems will translate across both automotive and robotic platforms.
The rapid funding cycles also suggest a sense of urgency among Chinese startups to establish dominance in a market that is expected to grow exponentially in the coming years. As China’s embodied AI market is projected to reach 1 trillion yuan by 2035, the race to secure intellectual property and manufacturing scale for critical components such as robotic hands is intensifying.
Risks of a Funding Bubble
However, the rapid influx of capital also raises questions about sustainability and the potential for market overheating. The aggressive valuations and compressed funding timelines are reminiscent of previous tech booms in China, where intense competition often led to significant market consolidation and the failure of many well-funded startups. As the technology matures and moves from the laboratory to commercial application, the focus will inevitably shift from fundraising to demonstrating reliable performance, scalable manufacturing, and a clear path to profitability. For now, the funding arms race in China’s robotic hand sector shows no signs of slowing, bringing the industry closer to the goal of creating truly versatile humanoid robots capable of operating in unstructured real-world environments.
The competitive dynamics are further complicated by the global nature of the challenge. US-based companies like Sanctuary AI and Apptronik, as well as Boston Dynamics, are also racing to develop dexterous manipulation capabilities. However, China’s combination of deep venture capital pools, strong government support, and a vast manufacturing ecosystem gives its startups a distinct structural advantage in scaling from prototype to mass production. The ability to iterate quickly and manufacture at scale will ultimately determine which companies can translate laboratory breakthroughs into commercially viable products, and China’s industrial ecosystem is uniquely suited to that challenge. The next 18 months will be a critical test of which companies can move from prototype demonstrations to reliable, high-volume manufacturing, and which will be left behind as the market consolidates rapidly around a handful of well-capitalized leaders.
The funding arms race in China’s robotic hand sector is ultimately a bet on the timeline for humanoid robots to become economically viable at scale. If that timeline proves shorter than expected, as many in the industry now believe, the companies that secured capital and manufacturing capacity in 2026 will be positioned to define the market for a generation. For investors and policymakers alike, the emergence of dexterous robotic hands as a standalone investment category signals that the humanoid robotics industry has matured beyond conceptual demonstrations into a serious industrial competition. The capital flowing into Xynova and AgiLink today is not speculative enthusiasm — it is a calculated bet that the component supply chain for humanoid robots will be one of the most valuable industrial sectors of the next decade.